Shanghai Medicilon Inc Tangible Net Worth Ratio
Shanghai Medicilon Inc tangible net worth ratio. Shanghai Medicilon Inc (688202) has a Tangible Net Worth Ratio of 86.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥264.72 Million) from net assets (CN¥2.00 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Shanghai Medicilon Inc (688202) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shanghai Medicilon Inc (2016–2025)
Tangible net worth ratio of Shanghai Medicilon Inc from 2016 to 2025. This chart shows how Shanghai Medicilon Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 86.8%, reflecting net assets of CN¥2.00 Billion with intangible assets of CN¥264.72 Million CNY. See working capital to net assets of Shanghai Medicilon Inc to evaluate short-term liquidity relative to the company's equity base.
Shanghai Medicilon Inc Tangible Net Worth Ratio by Year (2016–2025)
Shanghai Medicilon Inc tangible net worth ratio by year from 2016 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Medicilon Inc from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Shanghai Medicilon Inc.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.1% | CN¥1.93 Billion | CN¥269.20 Million | CN¥2.62 Billion | ▼ -0.9 pp |
| 2024 | 87.0% | CN¥2.14 Billion | CN¥278.15 Million | CN¥2.82 Billion | ▼ -1.6 pp |
| 2023 | 88.6% | CN¥2.51 Billion | CN¥286.90 Million | CN¥3.27 Billion | ▲ +6.9 pp |
| 2022 | 81.7% | CN¥1.60 Billion | CN¥294.05 Million | CN¥2.33 Billion | ▼ -0.9 pp |
| 2021 | 82.6% | CN¥1.33 Billion | CN¥231.61 Million | CN¥1.79 Billion | ▲ +3.2 pp |
| 2020 | 79.3% | CN¥1.14 Billion | CN¥235.02 Million | CN¥1.36 Billion | ▼ -20.2 pp |
| 2019 | 99.5% | CN¥1.00 Billion | CN¥4.91 Million | CN¥1.13 Billion | ▲ +0.9 pp |
| 2018 | 98.6% | CN¥347.89 Million | CN¥4.74 Million | CN¥472.95 Million | ▼ -1.0 pp |
| 2017 | 99.6% | CN¥287.32 Million | CN¥1.11 Million | CN¥389.61 Million | ▼ -0.2 pp |
| 2016 | 99.8% | CN¥246.09 Million | CN¥449.46K | CN¥344.90 Million | — |